Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Name: Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
SKU: 3067
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: acetylcholine, dopamine, elliott-richelson, histamine, norepinephrine, serotonin

Description

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

VOL 3 No. 3 Full Issue – March 2001

Neuropharmacology of Paroxetine

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

Related products

Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

VOL 3 No. 3 Full Issue – March 2001

Neuropharmacology of Paroxetine